"Do I qualify?" is the most common GLP-1 question, and the honest answer is that no website can tell you — only a licensed physician can, after reviewing your information. But you can understand what that review looks at, so you know what to expect before you start. Here is the plain version.
What a physician reviews
A telehealth evaluation is a real medical review, not a checkbox. A clinician generally considers:
- Your health history — current conditions, past medical and surgical history, and anything relevant to how a medicine like this would fit.
- Your medications and allergies — to check for interactions and contraindications.
- Your goals and the clinical picture — for FDA-approved weight-management medicines, the labeling is tied to weight-related criteria and related health conditions; a physician applies those.
- Labs, where appropriate — some programs require or recommend blood work before or during treatment.
The point of the review is to decide whether a given medication is appropriate for you — and sometimes the appropriate answer is "not this," or "not yet," or "let's address something else first."
Things that may rule it out
A physician is specifically watching for reasons this class of medicine would not be safe, including:
- A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- A history of pancreatitis or certain gallbladder or gastrointestinal conditions.
- Pregnancy, planning pregnancy, or breastfeeding.
- Certain other conditions or medications that make it a poor fit.
This isn't a complete list — it's why the evaluation exists. Not everyone qualifies, and that's the system working as intended.
Where you live matters, too
We can't serve every state. Because of state regulations, the program is not available in Alaska, Mississippi, New Jersey, or Texas. If you're in one of those states, the questionnaire will stop you before you reach a program — not an oversight, a compliance requirement.
FDA-approved vs. compounded — a quick note
Qualifying for an FDA-approved weight-management medication (like Wegovy or Zepbound) is tied to that drug's labeled criteria. Compounded semaglutide or tirzepatide is a different path — offered only as physician-directed metabolic care when a clinician judges a compounded preparation appropriate, with no weight-loss claims attached. Which path (if either) fits is part of what the review determines.
What happens after you start
You complete an intake, a licensed physician reviews it, and a prescription is issued only if it's appropriate — you're charged only after approval. If it's not a fit, you're told why. There's no obligation and no pressure, and nobody at OS Reboot practices medicine — the clinical decision belongs to the independent licensed medical network.
Ready to find out where you stand? A telehealth review is the honest way to get an answer specific to you.
Educational information, not medical advice, a diagnosis, or a prescription. OS Reboot does not practice medicine or operate a pharmacy; every medical decision is made by a licensed clinician based on your individual evaluation. Not everyone qualifies; no outcomes are guaranteed.